Multicenter, open-label follow-up study on the safety of enteric-coated mycophenolate sodium in renal transplant patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2005
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 07 Dec 2005 New trial record.